Demonstrate an 15% increase in the rate of clinical pregnancy in women with inoperable
intramural fibroids not distorting the uterine cavity within a program OVD, after
administration of uPA in a dose of 10 mg orally daily for 12 weeks
Phase:
Phase 3
Details
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA